The chief executive of NHS Greater Manchester Integrated Care Board, Mark Fisher, has been cleared to return to his role after an internal whistleblowing investigation found no case for further action. The investigation, launched in late 2025, had led to Fisher being suspended on a “precautionary basis” while the organisation followed formal whistleblowing, HR and governance procedures.
NHS Greater Manchester confirmed at the time that no assumptions should be drawn during the process and that confidentiality would be maintained until the inquiry concluded. Following the completion of the investigation in early 2026, the ICB has now confirmed that no wrongdoing was identified and that Fisher will resume his duties, bringing an end to months of uncertainty at one of England’s largest integrated care systems.
Background: suspension and governance processes
Fisher was suspended in December 2025 after concerns were raised through formal whistleblowing channels. The organisation emphasised that the suspension was not indicative of guilt but a standard procedural step designed to ensure fairness and integrity during the investigation.
At the time, an NHS Greater Manchester spokesperson stated that the process was being conducted “in accordance with our whistleblowing, HR and governance frameworks”, adding that “no findings have been made at this stage”. Interim leadership arrangements were put in place, with deputy chief executive Colin Scales stepping in to maintain “continuity and stability” across the system. The nature of the original complaint was not publicly disclosed, reflecting standard practice in whistleblowing cases to protect all parties involved.
Leadership stability restored at a critical time
The resolution of the investigation comes at a significant moment for NHS Greater Manchester, which oversees a population of more than 2.8 million people and manages a multibillion-pound health and care budget. As one of the most advanced integrated care systems in England, Greater Manchester plays a key role in delivering national priorities, including elective recovery, prevention and digital transformation.
Leadership continuity is particularly important as systems navigate financial pressures, workforce challenges and ongoing reforms linked to integrated care boards. Fisher, who has led the ICB since its creation in 2022, had already announced plans to retire in 2026 following a 42-year career in public service. His return is expected to provide short-term stability as the organisation continues to deliver its strategic objectives.
Streeting emphasises fairness and accountability
Health Secretary Wes Streeting has welcomed the conclusion of the investigation, using the case to underline the importance of both accountability and due process within the NHS. In an official statement, Streeting said: “It is right that concerns are thoroughly investigated, but it is equally important that individuals are treated fairly and not judged before the facts are established.”
He added that the NHS must maintain robust governance standards, stating: “We must ensure strong accountability while also upholding a culture where staff feel safe to speak up and leaders are supported to do their jobs.” Streeting’s comments reflect a broader effort to balance transparency with fairness, particularly in high-profile leadership cases.
Implications for whistleblowing culture and governance
The case highlights the growing prominence of whistleblowing frameworks within the NHS, as organisations seek to encourage staff to raise concerns while ensuring appropriate processes are followed. Experts note that the use of precautionary suspension, while sometimes controversial, remains a common mechanism designed to protect both the integrity of investigations and the individuals involved.
The outcome may also reinforce confidence in governance processes, demonstrating that allegations are taken seriously but assessed rigorously before conclusions are reached.
However, such cases can still have reputational and operational impacts, particularly when they involve senior leaders and attract public attention. For integrated care boards, which are relatively new entities, the episode underscores the importance of clear governance structures, transparent processes and effective communication.
Digital governance and system-wide coordination
The investigation also highlights the role of digital systems in supporting governance and organisational oversight. Modern whistleblowing frameworks increasingly rely on secure reporting platforms, data tracking and audit trails to ensure that concerns are handled consistently and transparently.
In large systems such as Greater Manchester, digital tools can help coordinate investigations across multiple organisations, ensuring that information is shared appropriately while maintaining confidentiality. Health technology leaders argue that further investment in governance-related digital infrastructure could strengthen accountability and reduce delays in resolving complex cases.
A return to business as usual?
With the investigation concluded and Fisher cleared, NHS Greater Manchester is expected to return to normal operations under his leadership in the short term. The episode, however, serves as a reminder of the scrutiny faced by senior NHS leaders and the importance of robust governance frameworks in maintaining trust.
For policymakers and system leaders, the challenge will be to ensure that whistleblowing processes remain both effective and fair, supporting transparency without undermining organisational stability. As the NHS continues to evolve, cases such as this will play a key role in shaping how leadership accountability and governance are managed across the system.
